Statistical power of clinical trials increased while effect size remained stable: An empirical analysis of 136,212 clinical trials between 1975 and 2014

Herm J. Lamberink, Willem M. Otte, Michel R.T. Sinke, Daniël Lakens, Paul P. Glasziou, Joeri K. Tijdink, Christiaan H. Vinkers

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)
55 Downloads (Pure)

Abstract

Objectives: To study the statistical power of randomized clinical trials and examine developments over time. Study Design and Setting: We analyzed the statistical power in 136,212 clinical trials between 1975 and 2014 extracted from meta-analyses from the Cochrane database of systematic reviews. We determined study power to detect standardized effect sizes, where power was based on the meta-analyzed effect size. Average power, effect size, and temporal patterns were examined for all meta-analyses and a subset of significant meta-analyses. Results: The number of trials with power ≥80% was low (7%) but increased over time: from 5% in 1975–1979 to 9% in 2010–2014. In significant meta-analyses, the proportion of trials with sufficient power increased from 9% to 15% in these years (median power increased from 16% to 23%). This increase was mainly due to increasing sample sizes, while effect sizes remained stable with a median Cohen's h of 0.09 (interquartile range 0.04–0.22) and a median Cohen's d of 0.20 (0.11–0.40). Conclusion: This study demonstrates that sufficient power in clinical trials is still problematic, although the situation is slowly improving. Our data encourage further efforts to increase statistical power in clinical trials to guarantee rigorous and reproducible evidence-based medicine.

Original languageEnglish
Pages (from-to)123-128
Number of pages6
JournalJournal of Clinical Epidemiology
Volume102
DOIs
Publication statusPublished - 1 Oct 2018

Fingerprint

Meta-Analysis
Clinical Trials
Evidence-Based Medicine
Sample Size
Randomized Controlled Trials
Databases

Cite this

Lamberink, Herm J. ; Otte, Willem M. ; Sinke, Michel R.T. ; Lakens, Daniël ; Glasziou, Paul P. ; Tijdink, Joeri K. ; Vinkers, Christiaan H. / Statistical power of clinical trials increased while effect size remained stable : An empirical analysis of 136,212 clinical trials between 1975 and 2014. In: Journal of Clinical Epidemiology. 2018 ; Vol. 102. pp. 123-128.
@article{a279f45a05fc46a383566b15bd2e09f4,
title = "Statistical power of clinical trials increased while effect size remained stable: An empirical analysis of 136,212 clinical trials between 1975 and 2014",
abstract = "Objectives: To study the statistical power of randomized clinical trials and examine developments over time. Study Design and Setting: We analyzed the statistical power in 136,212 clinical trials between 1975 and 2014 extracted from meta-analyses from the Cochrane database of systematic reviews. We determined study power to detect standardized effect sizes, where power was based on the meta-analyzed effect size. Average power, effect size, and temporal patterns were examined for all meta-analyses and a subset of significant meta-analyses. Results: The number of trials with power ≥80{\%} was low (7{\%}) but increased over time: from 5{\%} in 1975–1979 to 9{\%} in 2010–2014. In significant meta-analyses, the proportion of trials with sufficient power increased from 9{\%} to 15{\%} in these years (median power increased from 16{\%} to 23{\%}). This increase was mainly due to increasing sample sizes, while effect sizes remained stable with a median Cohen's h of 0.09 (interquartile range 0.04–0.22) and a median Cohen's d of 0.20 (0.11–0.40). Conclusion: This study demonstrates that sufficient power in clinical trials is still problematic, although the situation is slowly improving. Our data encourage further efforts to increase statistical power in clinical trials to guarantee rigorous and reproducible evidence-based medicine.",
author = "Lamberink, {Herm J.} and Otte, {Willem M.} and Sinke, {Michel R.T.} and Dani{\"e}l Lakens and Glasziou, {Paul P.} and Tijdink, {Joeri K.} and Vinkers, {Christiaan H.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.jclinepi.2018.06.014",
language = "English",
volume = "102",
pages = "123--128",
journal = "Journal of Chronic Diseases",
issn = "0895-4356",
publisher = "Elsevier",

}

Statistical power of clinical trials increased while effect size remained stable : An empirical analysis of 136,212 clinical trials between 1975 and 2014. / Lamberink, Herm J.; Otte, Willem M.; Sinke, Michel R.T.; Lakens, Daniël; Glasziou, Paul P.; Tijdink, Joeri K.; Vinkers, Christiaan H.

In: Journal of Clinical Epidemiology, Vol. 102, 01.10.2018, p. 123-128.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Statistical power of clinical trials increased while effect size remained stable

T2 - An empirical analysis of 136,212 clinical trials between 1975 and 2014

AU - Lamberink, Herm J.

AU - Otte, Willem M.

AU - Sinke, Michel R.T.

AU - Lakens, Daniël

AU - Glasziou, Paul P.

AU - Tijdink, Joeri K.

AU - Vinkers, Christiaan H.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Objectives: To study the statistical power of randomized clinical trials and examine developments over time. Study Design and Setting: We analyzed the statistical power in 136,212 clinical trials between 1975 and 2014 extracted from meta-analyses from the Cochrane database of systematic reviews. We determined study power to detect standardized effect sizes, where power was based on the meta-analyzed effect size. Average power, effect size, and temporal patterns were examined for all meta-analyses and a subset of significant meta-analyses. Results: The number of trials with power ≥80% was low (7%) but increased over time: from 5% in 1975–1979 to 9% in 2010–2014. In significant meta-analyses, the proportion of trials with sufficient power increased from 9% to 15% in these years (median power increased from 16% to 23%). This increase was mainly due to increasing sample sizes, while effect sizes remained stable with a median Cohen's h of 0.09 (interquartile range 0.04–0.22) and a median Cohen's d of 0.20 (0.11–0.40). Conclusion: This study demonstrates that sufficient power in clinical trials is still problematic, although the situation is slowly improving. Our data encourage further efforts to increase statistical power in clinical trials to guarantee rigorous and reproducible evidence-based medicine.

AB - Objectives: To study the statistical power of randomized clinical trials and examine developments over time. Study Design and Setting: We analyzed the statistical power in 136,212 clinical trials between 1975 and 2014 extracted from meta-analyses from the Cochrane database of systematic reviews. We determined study power to detect standardized effect sizes, where power was based on the meta-analyzed effect size. Average power, effect size, and temporal patterns were examined for all meta-analyses and a subset of significant meta-analyses. Results: The number of trials with power ≥80% was low (7%) but increased over time: from 5% in 1975–1979 to 9% in 2010–2014. In significant meta-analyses, the proportion of trials with sufficient power increased from 9% to 15% in these years (median power increased from 16% to 23%). This increase was mainly due to increasing sample sizes, while effect sizes remained stable with a median Cohen's h of 0.09 (interquartile range 0.04–0.22) and a median Cohen's d of 0.20 (0.11–0.40). Conclusion: This study demonstrates that sufficient power in clinical trials is still problematic, although the situation is slowly improving. Our data encourage further efforts to increase statistical power in clinical trials to guarantee rigorous and reproducible evidence-based medicine.

UR - http://www.scopus.com/inward/record.url?scp=85050569494&partnerID=8YFLogxK

U2 - 10.1016/j.jclinepi.2018.06.014

DO - 10.1016/j.jclinepi.2018.06.014

M3 - Article

VL - 102

SP - 123

EP - 128

JO - Journal of Chronic Diseases

JF - Journal of Chronic Diseases

SN - 0895-4356

ER -